The University of Queensland Homepage
Takes you back to the UQ reSEARCHers Homepage You are at the UQ reSEARCHers site


 Biography

I am primarily interested in advancing brain monitoring techniques to improve outcomes for critically ill patients (e.g., extremely premature babies; stroke patients)

Dr Simon Finnigan commenced a Senior Research Fellow appointment in the UQ Centre for Clinical Research in 2010, with the support of a NHMRC Career Development Award. This follows Dr Finnigan's Research Fellowship at the Trinity College Institute of Neuroscience, Trinity College Dublin (University of Dublin) and St James’s Hospital, Dublin (the largest hospital in Ireland). Dr Finnigan is a neurophysiologist and his primary field of expertise is electroencephalography (EEG) and secondarily magnetic resonance imaging (MRI) methods applied to brain monitoring of critically ill patients. His new appointment is within the Clinical Neurosciences Group of UQ-CCR under the leadership of Prof Paul Colditz. The primary aims of his NHMRC-funded fellowship are to advance the detection, interpretation and tracking of vital brain abnormalities in critically ill newborn babies in the hours after birth, and thereby to deliver important information which can support treatment decisions and ultimately, help achieve better outcomes for such babies.

Throughout his career Dr Finnigan has worked productively on a range of multi-disciplinary clinical research projects, including R&D collaborations with industry partners such as GlaxoSmithKline Pharmaceuticals (in Australia, UK and Ireland), Intel Digital Health (USA and Europe), BrainZ Instruments Ltd (Auckland) and Natus Medical Inc (USA). Before moving to Dublin Dr Finnigan successfully undertook a series of acute stroke brain monitoring studies in collaboration with the RBWH Neurology Department (primarily the late Dr Jonathan Chalk) and with RBWH-based clinical neuroimaging expert, Dr Stephen Rose. He has authored numerous papers published in high-quality international journals such as 'Stroke', 'Neuropsychologia' and 'Clinical Neurophysiology', and has reviewed papers submitted to the latter and other international journals. Dr Finnigan is highly motivated to continue to pursue translational research and development, involving clinical neurophysiology and other techniques, which can ultimately help improve the quality of human lives in the face of brain damage or disease; and help deliver socio-economic benefits.

 Keywords